University of Strathclyde

Continuous Manufacturing and Crystallisation (CMAC)

UKRPIF award: £11.4 million
Officially opened: March 2015

The UK Research Partnership Investment Fund (UKRPIF) enabled the University of Strathclyde to develop its CMAC facilities within the Technology and Innovation Centre, funding the procurement and installation of a comprehensive suite of continuous processing, process analysis, and characterisation equipment.

The facilities support pharmaceutical manufacturing research conducted within the institute’s Engineering and Physical Sciences Research Council (EPSRC)-funded CMAC Future Manufacturing Research Hub, and is utilised by more than 130 staff and researchers, including academics, post docs and over 45 PhD students.

CMAC is a multi-institution centre of research. The following institutions are partners alongside the University of Strathclyde:

  • University of Bath
  • University of Cambridge
  • University of Sheffield
  • Imperial College London
  • University of Leeds
  • Loughborough University

The UKRPIF award leveraged co-investment from a number of big pharma companies and CMAC now has a number of strategic industry partners and cofunders working to develop new chemical and pharmaceutical products, from large companies including AstraZeneca, GSK, Novartis, Bayer, Lilly, Roche and Pfizer, to a range small and medium-sized enterprises.